The CDSCO’s August 2024 report categorized several medications under its “Not of Standard Quality (NSQ Alert)” list, which ...

The central drug regulator released two lists – one was a list of 48 drugs that failed the quality tests and another had ...

One of the major dangers of taking substandard medications is the risk of prolonged health issues. PCM (paracetamol), for ...

The Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard ...

Estonia may be a small country with a population of just 1.3 million – about the size of Dallas, Texas – but it has quite a bit going for it when it comes to biotech companies. Due to its relatively ...

Three drug startups collectively raised more than $700 million in initial public offerings Thursday, a flurry of activity after a largely fallow summer in which few biotechnology companies made the ...

The Biotech Beach Hotbed includes San Diego, Los Angeles and the surrounding (Torrey Pines, Thousand Oaks) regions of Southern California. SoCal is well-known for its sprawling beaches and ...

A trio of biotech companies sold shares in their initial ... expanded its IPO to sell 17.5 million shares at $18 each, at the top of the price range, to raise $315 million, according to a statement ...

The Federal Government, through the National Biosafety Management Agency on Tuesday, conducted the regulatory trial of biotech tomatoes preparatory to release into the Nigerian market. The biotech ...

(Bloomberg) -- A trio of biotech companies sold shares in their ... expanded its IPO to sell 17.5 million shares at $18 each, at the top of the price range, to raise $315 million, according ...

RA Capital Management owns a 10.5% stake after the IPO. As of the end of the second quarter of this year, Bicara reported a cash position of $203.9 million. Combined with the IPO proceeds ...